NAFDAC warns open-drug marketers against substandard products

The National Agency for Food and Drug Administration and Control (NAFDAC) has cautioned open-drug marketers against selling substandard drugs. Prof. Mojisola Adeyeye, Director-General of NAFDAC, issued the warning during an